[1]
|
B. Eliasson, J. Cederholm, K. Eeg-Olofsson, et al., “Clinical Usefulness of Different Lipid Measures for Prediction of Coronary Heart Disease in Type 2 Diabetes,” Diabetes Care, Vol. 35, No. 5, 2011, pp. 2095-2100.
doi:10.2337/dc11-0209
|
[2]
|
“American Diabetes Association 2012 Executive Summary: Standards of Medical Care in Diabetes,” Diabetes Care, Vol. 35, No. 1, 2012, pp. S4-S10.
|
[3]
|
“Emerging Risk Factors Collaboration, Major Lipids, Apolipoproteins, and Risk of Vascular Disease,” Journal of the American Medical Association, Vol. 302, No. 18, 2009, pp. 1993-2000. doi:10.1001/jama.2009.1619
|
[4]
|
S. Van Dieren, U. Nothlings, A. M. Van der Schouw, et al., “Non-Fasting Lipids and Risk of Cardiovascular Disease in Patients with Diabetes Mellitus,” Diabetologia, Vol. 54, No. 1, 2011, pp. 73-77.
doi:10.1007/s00125-010-1945-z
|
[5]
|
A. D. Gutierrez, E. Duran-Valdez, I. Robinson, D. Gonzalez de Serna and D. S. Schade, “Does Short-Term Vitamin C Reduce Cardiovascular Risk in Type 2 Diabetes?” Endocrine Practice, 2013, in press.
|
[6]
|
S. Gregersen, D. Samocha-Bonet, L. K. Heilbronn and L. V. Campbell, “Inflammatory and Oxidative Stress Responses to High-Carbohydrate and High-Fat Meals in Healthy Humans,” Journal of Nutrition and Metabolism, Vol. 2012, 2012, Article ID: 238056.
doi:10.1155/2012/238056
|
[7]
|
M. F. Carroll and D. S. Schade, “The Dawn Phenomenon Revisited: Implications for Diabetes Therapy,” Endocrine Practice, Vol. 11, No. 1, 2005, pp. 55-64.
doi:10.4158/EP.11.1.55
|
[8]
|
R. J. Bondar and D. C. Mead, “Evaluation of Glucose-6-Phosphate Dehydrogenase from Leuconostoc Mesenteroides in the Hexokinase Method for Determining Glucose in Serum,” Clinical Chemistry, Vol. 20, No. 5, 1974, pp. 586-590.
|
[9]
|
L. Andersen, B. Dinesen, P. N. Jorgensen, et al., “Enzyme Immunoassay for Intact Human Insulin in Serum or Plasma,” Clinical Chemistry, Vol. 39, No. 4, 1993, pp. 578-582.
|
[10]
|
P. Fossati and L. Prencipe, “Serum Triglycerides Determined Colorimetrically with an Enzyme That Produces Hydrogen Peroxide,” Clinical Chemistry, Vol. 28, No. 10, 1982, pp. 2077-2080.
|
[11]
|
C. C. Allain, L. S. Poon, C. S. Chan, et al., “Enzymatic Determination of Total Serum Cholesterol,” Clinical Chemistry, Vol. 20, No. 4, 1974, pp. 470-475.
|
[12]
|
W. T. Friedewald, R. I. Levy and D. S. Fredrickson, “Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, without Use of the Preparative Ultracentrifuge,” Clinical Chemistry, Vol. 18, 1972, pp. 499-502.
|
[13]
|
J. Hintze, “NCSS and PASS Number Cruncher Statistical System,” Jatsvukke Utah, 2001.
|
[14]
|
M. R. Stoline, “The Status of Multiple Comparisons: Simultaneous Estimation of All Pairwise Comparisons in One-Way ANOVA Designs,” The American Statistician, Vol. 35, No. 3, 1981, pp. 134-141.
|
[15]
|
S. Mora, N. Rifai, J. E. Buring, et al., “Fasting Compared with Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events,” Circulation, Vol. 118, No. 10, 2008, pp. 993-1001.
doi:10.1161/CIRCULATIONAHA.108.777334
|
[16]
|
J. H. M. deVries, P. L. Zock, R. P. Mensink, et al., “Underestimation of Energy Intake by 3-d Records Compared with Energy Intake to Maintain Body Weight in 269 Nonobese Adults,” American Journal of Clinical Nutrition, Vol. 60, No. 6, 1994, pp. 855-860.
|